Under construction – not a live service
Sign in
Taking people in ItalyNo phase

Italian Version of a Stomach and Bowel Symptom Questionnaire for Parkinson's Disease

Translates and tests an Italian questionnaire on digestive symptoms in adults with Parkinson's disease.

Plain-language title generated from the registry record
Registry title: Italian Translation and Validation of the GIDS-PD Scale for Parkinson's Disease

Key facts

Where
Milan, Padova, Tricase, and Verona, ItalySee the 5 sites

AI summary: who the study is looking for

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with Parkinson's disease who understand Italian. It tests an Italian version of a questionnaire about stomach and bowel symptoms.

Age
18 years or older
Sex
All sexes can join
Disease stage
Parkinson's disease diagnosed by the Movement Disorder Society (MDS) criteria. People in the terminal phase of the disease cannot join.

Main reasons for not taking part

  • In the terminal phase of the disease
  • Clinically relevant cognitive impairment
  • A parkinsonism other than Parkinson's disease
  • Unable to understand and sign the informed consent form

Read by machine on 9 November 2026.

Where in Italy

  • Fondazione IRCCS Istituto Neurologico Carlo BestaMilan, ItalyContact: Roberto Eleopra, MDTaking people
  • Ospedale Universitario Luigi Sacco, Milano, ItaliaMilan, ItalyContact: Leonardo Pantoni, MDNot yet recruiting
  • Unità Parkinson e Disturbi del Movimento, Dipartimento di Neuroscienze(DNS), Università di Padova, Padova, ItaliaPadova, ItalyContact: Angelo AntoniniNot yet recruiting
  • Centro per le Malattie Neurodegenerative e l'Invecchiamento Cerebrale, Università degli Studi di Bari "Aldo Moro" presso la Pia Fondazione "Card. G. Panico", Tricase, ItaliaTricase, ItalyContact: Daniele Urso, MDNot yet recruiting
  • Unità di Neurologia, Divisione Malattia di Parkinson e Disturbi del Movimento, Dipartimento di Neuroscienze, Biomedicina e Scienze del Movimento, Università di Verona, ItaliaVerona, ItalyContact: Michele Tinazzi, MDNot yet recruiting

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Trial code
NCT07316751
Record updated
11 February 2026
Original description
This study aims to translate and validate the Gastrointestinal Dysfunction Scale for Parkinson's Disease (GIDS-PD) into Italian to enable the assessment of gastrointestinal symptoms in Italian-speaking patients with Parkinson's disease. The psychometric properties of the translated instrument will be evaluated through a multi-phase process involving translation/back-translation, pre-testing, and large-scale validation across multiple Italian centersRead full original descriptionShow less

Italian Translation and Validation of the GIDS-PD Scale for Parkinson's Disease

This study aims to translate and validate the Gastrointestinal Dysfunction Scale for Parkinson's Disease (GIDS-PD) into Italian to enable the assessment of gastrointestinal symptoms in Italian-speaking patients with Parkinson's disease. The psychometric properties of the translated instrument will be evaluated through a multi-phase process involving translation/back-translation, pre-testing, and large-scale validation across multiple Italian centers

Inclusion: Age ≥18 years; Diagnosis of PD according to the Movement Disorder Society (MDS) diagnostic criteria (Postuma RB et al., 2015); Italian-native patients or patients that understand Italian correctly at least; Participants mentally and physically able to understand and sign the informed consent form.

Exclusion: Persons in the terminal phase of disease; Persons with clinically relevant cognitive impairment; Persons diagnosed with Parkinsonism other than PD.

ClinicalTrials.gov NCT07316751